Feed/Companies/Veradermics

Veradermics

As of 14 Oct 2026, Veradermics has raised $150M across 1 verified round on record; latest: $150 million Series C led by SR One, announced 16 Oct 2025.

BUILT ON

Visit site

Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company.

veradermics.comLinkedInNew Haven, Conn.Public company

LATEST ROUND

Series C

$150M · 2025-10-16

RAISED ON RECORD · USD

$150M

across 1 verified round

INVESTORS

1 lead

SOURCES

from 1 publisher

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series C

$150M · 2025-10-16

[ HISTORY ]

led by SR One

Round	Amount	Announced	Lead	Buzz
Series C [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$150M	2025-10-16	SR One	No recent discussion
1 source [ VERIFIED ] read against 1 source The page is published November 14, 2025, but its dateline is October 16, 2025; the dateline fixes the announcement date.

Veradermics

Company

Rounds

Sources

Profile

Investors

Veradermics

Rounds

Profile

Sources

Series C$150M2025-10-161 source

Investors

Series C$150M2025-10-1611 investors